|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/48 | |
| A61K 31/437 | |||
| A61K 31/5377 | |||
| A61P 7/04 |
| (11) | Patento numeris | 2950813 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14704915.9 |
| Europos patento paraiškos padavimo data | 2014-01-23 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-12-09 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-09-04 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/IB2014/058494 |
| Data | 2014-01-23 |
| (87) | Numeris | WO 2014/118677 |
| Data | 2014-08-07 |
| (30) | Numeris | Data | Šalis |
| 201361759332 P | 2013-01-31 | US |
| (72) |
CAMIRE, Rodney, US
FRUEBIS, Joachim, US
PITTMAN, Debra D., US
|
| (73) |
Pfizer Inc.,
235 East 42nd Street, New York, NY 10017,
US
The Children`s Hospital of Philadelphia, 3401 Civic Center Boulevard, Philadelphia, PA 19104, US |
| (54) | COMPOSITIONS AND METHODS FOR COUNTERACTING FACTOR XA INHIBITION |
| COMPOSITIONS AND METHODS FOR COUNTERACTING FACTOR XA INHIBITION |